{
    "clinical_study": {
        "@rank": "21764", 
        "acronym": "IRISS", 
        "brief_summary": {
            "textblock": "The study will include any patient treated with Iluvien at designated sites in European\n      countries where marketing authorization has been granted in order to obtain broader safety\n      and usage information."
        }, 
        "brief_title": "Iluvien Registry Safety Study", 
        "condition": "Any Patient Treated With Iluvien", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Any patient treated with Iluvien under this protocol will be included in the study.\n\n        Exclusion Criteria:\n\n          -  Patients/Guardians who are unable to understand and sign the Informed Consent will be\n             excluded from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Any patient treated with Iluvien"
            }
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01998412", 
            "org_study_id": "M-01-12-001"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "contact": {
                "last_name": "Kathleen Billman", 
                "phone": "678-527-1302"
            }, 
            "facility": {
                "address": {
                    "city": "Atlanta", 
                    "country": "United States", 
                    "state": "Georgia"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "An Open Label, Registry Study of the Safety of Iluvien\u00ae 190 Micrograms Intravitreal Implant in Applicator", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of participants with adverse events.", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01998412"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Alimera Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alimera Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "April 2014"
    }
}